Pages that link to "Q43099217"
Jump to navigation
Jump to search
The following pages link to SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients. (Q43099217):
Displaying 18 items.
- Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma (Q26739910) (← links)
- Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy (Q26767120) (← links)
- Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis (Q26770931) (← links)
- Adjuvant therapy for pancreas cancer in an era of value based cancer care (Q26775916) (← links)
- Neoadjuvant therapy for pancreas cancer: past lessons and future therapies (Q27004292) (← links)
- SIBLINGs and SPARC families: their emerging roles in pancreatic cancer (Q27027759) (← links)
- Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report (Q33750803) (← links)
- Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile (Q34042603) (← links)
- Novel role for matricellular proteins in the regulation of islet β cell survival: the effect of SPARC on survival, proliferation, and signaling (Q34431043) (← links)
- Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer (Q35671422) (← links)
- Molecular targeted approaches for treatment of pancreatic cancer. (Q36174910) (← links)
- SPARC expression and prognostic value in non-small cell lung cancer (Q37183762) (← links)
- Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival (Q39368816) (← links)
- Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer? (Q48219198) (← links)
- Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials (Q50191970) (← links)
- A Contemporary Review of the Treatment Landscape and the Role of Predictive and Prognostic Biomarkers in Pancreatic Adenocarcinoma. (Q52603515) (← links)
- The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection (Q61809694) (← links)
- Advances in pancreatic cancer biomarkers (Q64233995) (← links)